Find HDV and Determine Its Status in Turkey

Recruiting now

Conditions studied: Chronic Hepatitis D Infection, Fibrosis, Liver, Hepatocellular Carcinoma, Cirrhosis, Liver, Transmission Vertical

In brief

The aim of these study to determine the prevalence of hepatitis Delta virus (HDV) infections and the prognosis of HDV patients in Turkey's southeast. The investigators intend to arrange training sessions for 250 family physicians in Diyarbakir, Batman, Mardin, and Sanliurfa in order to determine those goals. The investigators will talk about diagnosing hepatitis B virus (HBV), HDV, hepatitis C virus (HCV), and Human Immunodeficiency virus (HIV) infections during these events. To ensure that patients with simultaneous HDV infection are evaluated for HIV/HCV and to detect liver fibrosis with a non-invasive method.

Key facts

Study ID

NCT06248580

Run by

Yaşar Bayındır, MD

People needed

20000

Starts

2024-03-11

Expected to finish

2025-03-01

Last updated by the study team

2024-08-12

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• Adults (Age≥18)
• Being HBsAg positive for at least six months
• Being a citizen of the Republic of Türkiye

You may not qualify if…

• There are no exclusion criteria in this study.

Where it is running

• Dicle University, Faculty of Medicine — Diyarbakır, Turkey (Türkiye) (enrolling)
• Guven Hospital — Ankara, Turkey (Türkiye) (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.